Letteratura

• Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R.L., Bernstein I.D. (2010). Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 16(2), 232-236

• Takenaka, C., Nishishita, N., Takada, N., Jakt, L. M., and Kawamata, S. (2010). Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53. Exp Hematol 38, 154-162

• Hütter G., Nowak D., Mossner M., Ganepola S., Müssig A., Allers K., Schneider T., Hofmann J., Kürcherer C., Blau O., Blau I. W., Hofmann W. K., Thiel E., (2009). Long-Term Control of HIV by CCR5  Delta32/Delta32 Stem-Cell Transplantation. N Engl J Med 360, 692-8

• Rebecca C. Schugar, Steven M. Chirieleison et al. High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J Biomed Biotechnol. 2009;2009:789526. Epub 2009 Dec 16

• Kenneth M. Dupont et al. Human stem cell delivery for treatment of large segmental bone defects. PNAS early edition 17 Dec 2009

• Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, Goland R, Leibel RL, Melton DA. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A. 2009 Aug 31

• Giorgetti, A., Montserrat, N., Aasen, T., Gonzalez, F., Rodriguez-Piza, I., Vassena, R., Raya, A., Boue, S., Barrero, M. J., Corbella, B. A., et al. (2009). Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Cell Stem Cell 5, 353-357.

• Haase, A., Olmer, R., Schwanke, K., Wunderlich, S., Merkert, S., Hess, C., Zweigerdt, R., Gruh, I., Meyer, J., Wagner, S., et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434-441.

• Burt, R. K., Loh, Y., Cohen, B., Stefoski, D., Balabanov, R., Katsamakis, G., Oyama, Y., Russell, E. J., Stern, J., Muraro, P., et al. (2009). Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 8, 244-253.

• Corsten MF, Shah K. Therapeutic stem cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol. 9(4): 376; 2008

• Mooney DJ., Vandenburgh H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2(3): 205; 2008

• Bjerre L. et al. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds. Biomaterials, 2008

• Hayani a et al. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics 119: 296, 2007

• Bearzi C. et al., Human cardiac stem cells. Proc Natl Acad Sci USA. 2007 Aug 28;104(35):14068-73. Epub 2007 Aug 20.

• Simpson D. et al. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25: 2350, 2007

• Nobuhiro N. et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 25: 2017, 2007

• Khon DB et al. Gene therapy for childhood immunological diseases. Bone Marrow Transplant. 2007

• Mahevas M et al. Haematopoietic stem cell transplantation in the treatment of autoimmune diseases. Rev Med Interne. 2007 Sep 21;

• Breems DA. Löwenber B. Acute myeloid leukemia and the position of autologous stem cell transplantation. Semin Hematol. 44(4):259; 2007.

• Muraro PA, Bielekova B. Emerging therapies for multiple sclerosis. Neurotherapeutics. 4(4): 676; 2007

• Tyndall et al. Adult stem cell treatment of scleroderma. Curr Opin Rheumatol. 19(6):604; 2007.

• Ogita M et al. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation. Clin Nephrol. 68(3):171; 2007

• Fousteri G. et al. Stopping diabetes in its tracks: autologous non-myeloablative stem cell transplantation. Regen Med. 2(5):845; 2007

• Cheuk DK et al. Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children.J Neurooncol. 2007 Sep 29

• Scolding N. et al. Autologous mesenchymal bone marrow stem cells: Practical considerations. J Neurol Sci. 2007

• Furfaro EM. Et al Do adult stem cells ameliorate the damaged myocardium? Human cord blood as a potential source of stem cells. Curr Vasc Pharmacol. 5(1):27; 2007

• Brunelli S. et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci USA. 2;104(1):264; 2007

• Seung HY et al. Complete spinal cord Injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte machrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells 25: 2066, 2007

• Ott MG. et al. Advances in the treatment of chronic granulomatous disease by gene therapy. Curr. Gene Ther. 7(3): 155; 2007

• O’Brien et al. No longer a biological waste product: umbilical cord blood. Med J Aust.: 184(8):407, 2006

• Leor J. et al. Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium. Stem Cells. 24(3):772; 2006

• Schoemans H et al. Adult umbilical cord blood transplantation: A comprehensive review. Bone Marrow transplant. 38: 83, 2006

• Leor J. et al. Human umbilical cord blood cells: a new alternative for myocardial repair? Cytotherapy. 7(3):251; 2005

• Love S et al. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain, Nature Medicine 11, 703-704, July 2005

• AFP (L’agence France Presse) Paralyzed woman walks again after stem cell therapy. November 28, 2004

• Fruchtman SM et al. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol Blood Marrow Transplant. 10: 741, 2004

• Stamm C et al. Autologous bone-marrow stem cell transplantation for myocardial regeneration. Lancet 361: 45, 2003

• Jaroscak J et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood 101(12):5061, 2003

• Barker JN, Wagner JE Umbilical cord blood transplantation for the treatment of cancer. Nature Reviews Cancer 3(7): 526, 2003

• Spurr EE et al. Cryopreserved human hematopoietic stem cells retain engraftment potential after extended (5-14 years) cryostorage. Cryobiology 44: 210, 2002

• Strauer BE et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106: 1913, 2002

• Assmus B et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 106: 3009, 2002

• McSweeney PA et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 100: 1602, 2002

• Hertzberg H et al. Recurrent disseminated retinoblastoma in a 7-year-old girl treated successfully by high-dose chemotherapy and CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 27(6): 653, 2001

• Rabusin M et al. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Haematologica 85: 81, 2000

• Aker M et al. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. Journal of Pediatric Hematology/Oncology 21(3): 237, 1999

• Cairo MS, Wagner JE. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 90: 4665, 1997

• Brichard B et al. Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. Journal of Pediatrics 128(2): 241, 1996

• Gluckman E et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med. 321: 1174, 1989